CLINICAL_TRIALS
trial_result
· 2023-05-12
Clinical Trial Update: Walnut Oral Immunotherapy for Tree Nut Allergy [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial updates for walnut oral immunotherapy in individuals with tree nut allergy; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arkansas | Conditions: Tree Nut Allergy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-05-12